Our project aimed to analyze the association between ERBB4 and different breast cancer clinical and molecular subtypes, in order to unveil potential strategies to exploit the modulation of its cellular signaling as a potential anticancer strategy. This evidence concerns the gene ERBB4 and breast carcinoma.